Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 180.00
Ask: 330.00
Change: 0.00 (0.00%)
Spread: 150.00 (83.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Investec prefers 888 over Entain

Tue, 28th Sep 2021 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

CITIGROUP RAISES BRITISH LAND TO 'NEUTRAL' ('SELL') - TARGET 526 (285) PENCE

----------

CITIGROUP RAISES LAND SECURITIES TO 'NEUTRAL' ('SELL') - TARGET 755 (506) PENCE

----------

UBS RAISES SPIRAX-SARCO PRICE TARGET TO 16,000 (12,500) PENCE - 'NEUTRAL'

----------

UBS RAISES DS SMITH PRICE TARGET TO 422 (414) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES PRUDENTIAL PRICE TARGET TO 1,680 (1,650) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS SAGE GROUP TO 'SELL' ('NEUTRAL') - TARGET 700 (660) PENCE

----------

INVESTEC INITIATES ENTAIN WITH 'HOLD' - TARGET 2,400 PENCE

----------

JPMORGAN RAISES UNITED UTILITIES TARGET TO 1,060 (1,050) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES FLUTTER TO 'BUY' (HOLD) - PRICE TARGET 17,400 (14,000) PENCE

----------

UBS CUTS MONDI PRICE TARGET TO 2,100 (2,200) PENCE - 'BUY'

----------

UBS CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 3,500 (3,600) PENCE - 'BUY'

----------

JPMORGAN RAISES ROLLS-ROYCE PRICE TARGET TO 150 (130) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

RBC RAISES ELECTROCOMPONENTS TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1,350 (1,070) PENCE

INVESTEC RESUMES 888 HOLDINGS WITH 'BUY' - TARGET 660 PENCE

JEFFERIES RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,450 (1,180) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

UBS RAISES RYANAIR PRICE TARGET TO 17.5 (16.8) EUR - 'NEUTRAL'

----------

PEEL HUNT RAISES NEXT FIFTEEN TO 'ADD' ('HOLD') - TARGET 1,220 (1,130) PENCE

----------

PEEL HUNT RAISES GAMMA COMMUNICATIONS TO 'BUY' ('HOLD') - TARGET 2,225 PENCE

----------

BERENBERG RAISES SUPERDRY PRICE TARGET TO 280 (235) PENCE - 'HOLD'

----------

PEEL HUNT INITIATES CLIPPER LOGISTICS WITH 'HOLD' - TARGET 865 PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
6 Apr 2021 08:19

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Read more
6 Apr 2021 08:08

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.

Read more
6 Apr 2021 07:53

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

Read more
21 Mar 2021 20:57

EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe

By Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands, an EU official said on Sunday.Former EU member Britain ha...

Read more
19 Mar 2021 10:29

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Read more
19 Mar 2021 07:50

Oxford Biomedica says Sanofi pulling out of haemophilia project

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.

Read more
3 Feb 2021 13:56

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

Read more
29 Jan 2021 09:11

UPDATE 1-EU holds out for more after AstraZeneca offered 8 mln extra COVID-19 shots

* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses produced there (Adds detail, background)By Francesco Guarascio and Sabine SieboldBRUSSELS, Jan 29 (Re...

Read more
18 Jan 2021 17:18

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

Read more
8 Jan 2021 09:40

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

Read more
8 Dec 2020 12:31

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University will come from Europe rather than a domestic supply chain, the country's Vaccine Taskforce said.The...

Read more
1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Read more
9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Read more
9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

Read more
4 Nov 2020 09:40

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.